#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials
Breakpoints
00:00
PKPD Target Achievement Work for Soul Back, Damn Delore Back, Damn, Damn
The next trial was presented by Sue Jada, Bob Mani, who is a pharmacist and she's absolutely awesome works up with the ICPD folks in New York. She presented the pop PK and then the PKPD target attainment work for soul back, damn delore back, damn. And we have covered on this podcast in previous episodes, the outcomes of the solar study in which it was found superior to Clisten for the treatment of Acinetobacter. So a really exciting drug that's on the horizon.
Transcript
Play full episode
